Publication | Closed Access

Efficacy and Safety of Inhaled Zanamivir in the Prevention of Influenza in Community-Dwelling, High-Risk Adult and Adolescent Subjects: A 28-day, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

VaccinationPreventive MedicineAdolescent SubjectsInhaled ZanamivirRespiratory InfectionInfectious Respiratory DiseasePlacebo-controlled TrialInfection ControlPublic HealthFlu VaccinationMedicineEpidemiologyInfluenza Vaccines